Literature DB >> 10221636

Effects of tetracycline on the filarial worms Brugia pahangi and Dirofilaria immitis and their bacterial endosymbionts Wolbachia.

C Bandi1, J W McCall, C Genchi, S Corona, L Venco, L Sacchi.   

Abstract

Wolbachia endosymbiotic bacteria have been shown to be widespread among filarial worms and could thus play some role in the biology of these nematodes. Indeed, tetracycline has been shown to inhibit both the development of adult worms from third-stage larvae and the development of the microfilaraemia in jirds infected with Brugia pahangi. The possibility that these effects are related to the bacteriostatic activity of tetracycline on Wolbachia symbionts should be considered. Here we show that tetracycline treatment is very effective in blocking embryo development in two filarial nematodes, B. pahangi and Dirofilaria immitis. Embryo degeneration was documented by TEM, while the inhibition of the transovarial transmission of Wolbachia was documented by PCR. Phylogenetic analysis on the ssrDNA sequence of the Wolbachia of B. pahangi confirms that the phylogeny of the bacterial endosymbionts is consistent with that of the host worms. The possibility that tetracycline inhibition of embryo development in B. pahangi and D. immitis is determined by cytoplasmic incompatibility is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221636     DOI: 10.1016/s0020-7519(98)00200-8

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  72 in total

1.  Determination of Wolbachia genome size by pulsed-field gel electrophoresis.

Authors:  L V Sun; J M Foster; G Tzertzinis; M Ono; C Bandi; B E Slatko; S L O'Neill
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

2.  Widespread prevalence of wolbachia in laboratory stocks and the implications for Drosophila research.

Authors:  Michael E Clark; Cort L Anderson; Jessica Cande; Timothy L Karr
Journal:  Genetics       Date:  2005-06-03       Impact factor: 4.562

Review 3.  Diurnally subperiodic filariasis in India-prospects of elimination: precept to action?

Authors:  A N Shriram; K Krishnamoorthy; B P Saha; Avijit Roy; V Kumaraswami; W A Shah; P Jambulingam; P Vijayachari
Journal:  Parasitol Res       Date:  2011-02-01       Impact factor: 2.289

4.  Improved efficacy of tetracycline by acaciasides on Dirofilaria immitis.

Authors:  S Datta; S Maitra; P Gayen; S P Sinha Babu
Journal:  Parasitol Res       Date:  2009-05-09       Impact factor: 2.289

5.  The Wolbachia Symbiont: Here, There and Everywhere.

Authors:  Emilie Lefoulon; Jeremy M Foster; Alex Truchon; C K S Carlow; Barton E Slatko
Journal:  Results Probl Cell Differ       Date:  2020

6.  Characterization of antibody responses to Wolbachia surface protein in humans with lymphatic filariasis.

Authors:  George A Punkosdy; David G Addiss; Patrick J Lammie
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

7.  The heme biosynthetic pathway of the obligate Wolbachia endosymbiont of Brugia malayi as a potential anti-filarial drug target.

Authors:  Bo Wu; Jacopo Novelli; Jeremy Foster; Romualdas Vaisvila; Leslie Conway; Jessica Ingram; Mehul Ganatra; Anita U Rao; Iqbal Hamza; Barton Slatko
Journal:  PLoS Negl Trop Dis       Date:  2009-07-14

8.  The bacterial symbiont Wolbachia induces resistance to RNA viral infections in Drosophila melanogaster.

Authors:  Luís Teixeira; Alvaro Ferreira; Michael Ashburner
Journal:  PLoS Biol       Date:  2008-12-23       Impact factor: 8.029

9.  Evidence for metabolic provisioning by a common invertebrate endosymbiont, Wolbachia pipientis, during periods of nutritional stress.

Authors:  Jeremy C Brownlie; Bodil N Cass; Markus Riegler; Joris J Witsenburg; Iñaki Iturbe-Ormaetxe; Elizabeth A McGraw; Scott L O'Neill
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

10.  Brugia malayi gene expression in response to the targeting of the Wolbachia endosymbiont by tetracycline treatment.

Authors:  Elodie Ghedin; Tiruneh Hailemariam; Jay V DePasse; Xu Zhang; Yelena Oksov; Thomas R Unnasch; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2009-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.